Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

CMND

$0.98-7.40%website ↗

Clearmind Medicine Inc.

Market Cap
$167,560.56
Sector
Materials
Industry
Pharmaceuticals
Beta
0.97
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
24.0x
buying
Congress
—
recent trades
Short Volume
21%
W/W +11.4pp

Market & Alt Data

News
15
recent articles
Activist
—
none active

Buy Activity

Buy Velocity Score
23.98x
Current Rate (90d)
23989.47/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
1

Sell Activity

Sell Velocity Score
23.98x
Sell Rate (90d)
2806.83/mo
Sell Baseline
0.00/mo
Unique Sellers (90d)
1
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-06-162026-06-18HRT FINANCIAL LP10% OwnerSale22.1K$3.31$73K81.4KView
2026-06-152026-06-17HRT FINANCIAL LP10% OwnerSale3,183$3.32$11K103.5KView
2026-06-122026-06-16HRT FINANCIAL LP10% OwnerSale2,102$3.36$7K106.7KView
2026-06-112026-06-12HRT FINANCIAL LP10% OwnerSale225.2K$0.12$28K1.84MView
2026-06-102026-06-12HRT FINANCIAL LP10% OwnerPurchase2.16M$0.15$330K2.06MView

Recent News

Unusual volume stocks in Tuesday's session
ChartMill · 2026-09-08
Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results
Yahoo · 2026-09-08
Clearmind Medicine Says Yale University’s IRB Approves Initiation Of Patient Recruitment For Parts B And C Of Phase I/II Clinical Trial Evaluating CMND‑100
Benzinga · 2026-09-08
Which stocks are experiencing notable movement on Friday?
ChartMill · 2026-09-04

Informational purposes only, not investment advice.

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 2026-09-04
Clearmind Medicine Agrees to Acquire 51% Stake in Charging Robotics for $2.5 Million
Yahoo · 2026-09-04
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 2026-09-04
Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis
Yahoo · 2026-09-04
Clearmind Medicine Stock Slides Friday: What's Happening?
Benzinga · 2026-09-04
Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
Yahoo · 2026-09-01
Clearmind Medicine Initiates Phase lla, Double-Blind, Placebo-Controlled Phase I/IIa Clinical Trial Evaluating CMND-100 For Treatment Of AUD
Benzinga · 2026-09-01
SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Yahoo · 2026-08-24
Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Yahoo Finance · 2026-08-24
Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint
Yahoo Finance · 2026-08-13
Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study
Yahoo Finance · 2026-08-06

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →
Pipeline
Phase 1
1 active trial · readout 2026-12